Merrimack Pharmaceuticals&#44&#59; Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (35)

Latest Posts

About This Stock More About This Stock
Morning Call For Thursday, Nov. 10
Article By: Jim Van Meerten
Thursday, November 10, 2016 9:03 AM EDT
Dec E-mini S&Ps (ESZ16 +0.32%) are up +0.58% at a 2-month high as drug makers and bank stocks rallied in pre-market trading on speculation the Trump administration will mean less regulatory oversight in those sectors than had Mrs. Clinton won.
In this article: BVX, ALXN, HLIT, AVID, MYL, TASR, URBN, ZLTQ, MACK, SHAK, RPD, SEDG, TRHC
Read
Merrimack Announced FDA Approval For Pancreatic Cancer Drug
Article By: Terry Chrisomalis
Friday, October 23, 2015 9:04 AM EDT
Merrimack received FDA approval for its pancreatic cancer drug, known as ONIVYDE. ONIVYDE treats patients with an advanced form of pancreatic cancer where patients had already failed gemcitabine based therapy -- a chemotherapy drug.
In this article: BXLT Also: MACK
Read

Latest Tweets for $MACK

No tweets yet!

PARTNER HEADLINES